Danshensu has anti-tumor activity in B16F10 melanoma by inhibiting angiogenesis and tumor cell invasion

European Journal of Pharmacology

Volumn 643, Issue 2-3, 2010, Pages 195-201

  Zhang, Li juan ^a   Chen, Lei ^a   Lu, Yin ^a   Wu, Jia ming ^a   Xu, Bo ^a   Sun, Zhi guang ^b   Zheng, Shi zhong ^a   Wang, Ai yun ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b AFFILIATED HOSPITAL OF NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Angiogenesis; Anti tumor activity; B16F10; Danshensu; Invasion

Indexed keywords

3 (3,4 DIHYDROXYPHENYL)LACTIC ACID; GELATINASE A; GELATINASE B; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MELANOMA; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VASCULARIZATION;

EID: 77955270626     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.06.045     Document Type: Article

References (38)

1. Bao S., Wu Q., Sathornsumetee S., Hao Y., Li Z., Hjelmeland A.B., Shi Q., McLendon R.E., Bigner D.D., Rich J.N. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res. 2006, 66:7843-7848.
2. Brown L.F., Detmar M., Claffey K., Nagy J.A., Feng D., Dvorak A.M., Dvorak H.F. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. Exs 1997, 79:233-269.
3. Chambers A.F., Naumov G.N., Varghese H.J., Nadkarni K.V., MacDonald I.C., Groom A.C. Critical steps in hematogenous metastasis: an overview. Surg. Oncol. Clin. N. Am. 2001, 10:243-255.
4. Chambers A.F., Groom A.C., MacDonald I.C. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2002, 2:563-572.
5. Chan K., Chui S.H., Wong D.Y., Ha W.Y., Chan C.L., Wong R.N. Protective effects of Danshensu from the aqueous extract of Salvia miltiorrhiza (Danshen) against homocysteine-induced endothelial dysfunction. Life Sci. 2004, 75:3157-3171.
6. Chirivi R.G., Garofalo A., Crimmin M.J., Bawden L.J., Stoppacciaro A., Brown P.D., Giavazzi R. Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor. Int. J. Cancer 1994, 58:460-464.
7. Cross M.J., Claesson-Welsh L. FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol. Sci. 2001, 22:201-207.
8. Ding M., Ye T.X., Zhao G.R., Yuan Y.J., Guo Z.X. Aqueous extract of Salvia miltiorrhiza attenuates increased endothelial permeability induced by tumor necrosis factor-alpha. Int. Immunopharmacol. 2005, 5:1641-1651.
9. Dong C., Wang Y., Zhu Y.Z. Asymmetric synthesis and biological evaluation of Danshensu derivatives as anti-myocardial ischemia drug candidates. Bioorg. Med. Chem. 2009, 17:3499-3507.
10. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nature Rev. Cancer 2002, 2:161-174.
11. Fan T.P., Yeh J.C., Leung K.W., Yue P.Y., Wong R.N. Angiogenesis: from plants to blood vessels. Trends Pharmacol. Sci. 2006, 27:297-309.
12. Folkman J. What is the evidence that tumours are angiogenesis dependent?. J. Natl. Cancer Inst. 1990, 82:4-6.
13. Folkman J. The role of angiogenesis in tumor growth. Semin. Cancer Biol. 1992, 3:65-71.
14. Gamble J.R., Matthias L.J., Meyer G., Kaur P., Russ G., Faull R., Berndt M.C., Vadas M.A. Regulation of in vitro capillary tube formation by anti-integrin antibodies. J. Cell Biol. 1993, 121:931-943.
15. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996, 86:353-364.
16. Hart I.R., Saini A. Biology of tumour metastasis. Lancet 1992, 339:1453-1457.
17. Hart I.R., Goode N.T., Wilson R.E. Molecular aspects of the metastatic cascade. Biochim. Biophys. Acta 1989, 989:65-84.
18. Hirayama R., Hirokawa K., Makinodan T. Change in the metastatic mode of B16 malignant melanoma in C57BL/6 mice with ageing and sex. IARC Sci. Publ. 1985, 58:85-96.
19. Hofmann U.B., Westphal J.R., Van Muijen G.N., Ruiter D.J. Matrix metalloproteinases in human melanoma. J. Invest. Dermatol. 2000, 115:337-344.
20. Hotchkiss K.A., Ashton A.W., Mahmood R., Russell R.G., Sparano J.A., Schwartz E.L. Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center. Mol. Cancer Ther. 2002, 1:1191-1200.
21. Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 1973, 52:2745-2756.
22. Kim C.W., Lee H.M., Lee T.H., Kang C., Kleinman H.K., Gho Y.S. Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin. Cancer Res. 2002, 62:6312-6317.
23. Liotta L.A., Tryggvason K., Garbisa S., Hart I., Foltz C.M., Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980, 284:67-68.
24. Liu G.T., Zhang T.M., Wang B.E., Wang Y.W. Protective action of seven natural phenolic compounds against peroxidative damage to biomembranes. Biochem. Pharmacol. 1992, 43:147-152.
25. Marin V., Kaplanski G., Gres S., Farnarier C., Bongrand P. Endothelial cell culture: protocol to obtain and cultivate human umbilical endothelial cells. J. Immunol. Methods 2001, 254:183-190.
26. Nagase H., Woessner J.F. Matrix metalloproteinases. J. Biol. Chem. 1999, 274:21491-21494.
27. Onitsuka M., Fujiu M., Shinma N., Maruyama H.B. New platelet aggregation inhibitors from Tan-Shen; radix of Salvia miltiorrhiza Bunge. Chem. Pharm. Bull. 1983, 31:1670-1675.
28. Pan J.Y., Zhao X.P., Shao Q. Pharmacokinetics and bioavailability study of danshensu in rat. China. J. Chin. Mat. Med. 2008, 33:146-149.
29. Repesh L.A. A new in vitro assay for quantitating tumor cell invasion. Invasion Metastasis 1989, 9:192-208.
30. Shibuya M. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J. Biochem. Mol. Biol. 2006, 39:469-478.
31. Tang M.K., Ren D.C., Zhang J.T., Du G.H. Effect of salvianolic acids from Radix Salviae miltiorrhizae on regional cerebral blood flow and platelet aggregation in rats. Phytomedicine 2002, 9:405-409.
32. Welch D.R. Technical considerations for studying cancer metastasis in vivo. Clin. Exp. Metastasis 1997, 15:272-306.
33. Wu L., Qiao H., Li Y., Li L. Cardioprotective effects of the combined use of puerarin and Danshensu on acute ischemic myocardial injury in rats. Phytother Res. 2007, 21:751-756.
34. Wyckoff J.B., Jones J.G., Condeelis J.S., Segall J.E. A critical step in metastasis: in vivo analysis of intravasation at the primary tumor. Cancer Res. 2000, 60:2504-2511.
35. Yan C.K., Liu W.W., Zeng F.D., Zhu X.H. Pharmacokinetics of Danshensu after single oral and intravenous administration in rabbits. Chin. J. Hosp. Pharm. 2005, 25:251-253.
36. Zeng G., Xiao H., Liu J., Liang X. Identification of phenolic constituents in Radix Salvia miltiorrhizae by liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun. Mass Spectrom. 2006, 20:499-506.
37. Zhao B.L., Jiang W., Zhao Y., Hou J.W., Xin W.J. Scavenging effects of Salvia miltiorrhiza on free radicals and its protection for myocardial mitochondrial membranes from ischemia-reperfusion injury. Biochem. Mol. Biol. Int. 1996, 38:1171-1182.
38. Zhao F.Q., Zheng N.X., Sato H., Adachi I., Horikoshi I. Pharmacokinetics of a Chinese traditional medicine, danshensu (3, 4-dihydroxyphenyllactic acid), in rabbits using high-performance liquid chromatography. Biol. Pharm. Bull. 1997, 20:285-287.